Citigroup Maintains Neutral on QuidelOrtho, Raises Price Target to $18

Benzinga · 6d ago
Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $13 to $18.